PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University College, London
University of Chicago
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
National Medical Research Radiological Centre of the Ministry of Health of Russia
University of Miami
Fondazione Italiana Linfomi - ETS
University of Washington
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
University of Cologne
University College, London
OHSU Knight Cancer Institute
Baylor College of Medicine
Beijing Children's Hospital
New York Medical College
St. Jude Children's Research Hospital
Northwestern University
The Lymphoma Academic Research Organisation
Fondazione Michelangelo
The Lymphoma Academic Research Organisation
Alliance for Clinical Trials in Oncology
University of Cologne
Massachusetts General Hospital
Stanford University
University of Cologne
Martin-Luther-Universität Halle-Wittenberg
Northwestern University
University of Wisconsin, Madison
King Abdullah International Medical Research Center
University of Miami
M.D. Anderson Cancer Center
University of Cologne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
University of Cologne
Massachusetts General Hospital
French Innovative Leukemia Organisation
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
University of Cologne
Fondazione Michelangelo
University College, London
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center